Skip to main content
OpenTrials
Completed

NCT Number: NCT05381324

Fistula-associated Anal Adenocarcinoma

The fistula-associated anal adenocarcinoma is rare in patients suffering from anal fistulas. There is only little data available for this patient collective making characterization and management of this disease difficult. Late diagnosis and advanced tumor stage at diagnosis result in poor clinical outcome. It is the purpose of this study to evaluate patients clinically diagnosed with a FAAC and to further perform a histopathological characterization of the available tumor specimen.

Completed

Looking for future studies?

Notify Me

Key information

About this study

All patients receiving surgery for an anal fistula in the years 1999 to 2019 at a tertiary university referral hospital were included in the analysis. A retrospective review of patients' charts was performed. Patients suffering from FAAC were eligible for histopathological analysis including immunohistochemistry and molecular profiling.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • anal fistula

Exclusion criteria

  • previous cancer of the anal canal

Treatment and study plan

Primary outcomes

  1. fistula-associated anal adenocarcinoma (FAAC)

    Time frame: 1999-2019

    include and analyze all patients suffering from FAAC

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Fistula-associated Anal Adenocarcinoma - a Twenty Years' Single-center Experience.

Important dates

Study start
1999
Primary completion
2019
Study completion
2022
First posted
May 19, 2022
Registry last updated
May 19, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.